Abstract:BACKGROUND:Primary liver cancer (PLC) is one of the most frequently seen tumors in China. Thirty years ago, patients with PLC were often detected at relatively late stage, with a palpable mass or marked clinical symptoms and poor prognosis. In the past 30 years, the diagnosis and treatment of PLC have been greatly improved with better prognosis.METHODS:In order to study the changes of PLC during the 30 years, the clinical data of 3250 patients with PLC from 10 medical institutions of China were collected, analyzed, and compared with those of 3254 PLC patients before the 30 years.RESULTS:In the 3250 patients aged 1-80 years, with an average age of 49.1 years, the male to female ratio (2.3:1) was lower than that before the 30 years. 73.5% of the 3250 patients sought medical advice within 3 months after the onset of the disease in contrast to 63.8% before the 30 years. Compared with those patients before the 30 years the symptoms and signs were alleviated generally. The HBsAg positive rate was 81.0%, but the HCV-Ab positive rate was 13.2%. The AFP level in 75% of patients was elevated, but in the remaining 25% was normal. 1912 patients (58.8%) were confirmed pathologically. Among them 1755 patients (91.8%) had hepatocellular carcinoma. The overall resection rate was 46.3%. Those who had early, middle, late stage carcinoma accounted for 29.9%, 51.5%, and 18.6% respectively in contrast to 0.4%, 47.0%, and 52.6% reported before the 30 years. The 1-, 3-, 5-year survival rates of the patients were 66.1%, 39.7%, and 32.5% respectively, whereas 93.5%, 70.1%, and 59.1% for the early stage patients, and 65.3%, 30.5%, and 23.5% for the middle stage patients. The half and 1-year survival rates of the late stage patients were 52.5%, and 14.7%, respectively.CONCLUSION:Comparison with the clinical data before and after the 30 years show that PLC can be diagnosed early. More PLC patients tend to undergo resection while receiving a better conservative treatment, which ensures a prognosis.

Some Therapeutic Concepts Converse of Primary Liver Cancer in China

[Advancements and Controversies in Conversion Therapy for Biliary Tract Malignant Tumors with Insufficient Future Liver Remnant].

The Changing Role of Surgery in the Treatment of Primary Liver Cancer

Changed Clinical Aspects of Primary Liver Cancer in China During the Past 30 Years.

Therapy of Primary Liver Cancer

Treatment of unresectable primary liver cancer: With reference to cytoreduction and sequential resection

Comprehensive treatment of liver cancer

Evolution and achievements of laparoscopic hepatocellular carcinoma in China over the past 20 years

Current Trends in Hepatocellular Carcinoma Therapies in China

The Trend of Liver Transplantation for Primary Hepatocellular Carcinoma

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).

Systemic Therapy Alters the Landscape of Surgery in Hepatocellular Carcinoma： Opportunities and Challenges

[Progress and implementing of novel surgical concepts and techniques in patients with resectable gastric cancer liver metastasis]

Ablative Approach for Primary Liver Cancer: Shanghai Experience.

The comprehensive therapy for primary liver cancer

Research progress in the preoperative radiotherapy and immunotherapy for primary liver cancer

Chinese Expert Consensus on Refined Diagnosis, Treatment, and Management of Advanced Primary Liver Cancer (2023 Edition)

Precise Combination of Systemic Therapy and Hepatic Surgery

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

Consensus on the tertiary prevention of primary liver cancer

The history of interventional therapy for liver cancer in China